Deals NZ biotech chooses Australia for IPO By Saskia Pickles Perth based stockbroking firm Patersons Securities is punting on investors’ emerging appetite for biotech stocks, agreeing to underwrite New Zealand biopharmaceutical company Innate Immunotherapeutics’s $16.5 million initial public offering. 16 Oct 2013
McMillan at Paterson Ord Minnett By Staff Reporters Paterson Ord Minnett has appointed Andrew McMillan director of corporate finance. Mr McMillan was formerly the director of corporate finance at KPMG. 01 Apr 2003
Paterson adds to team By Staff Reporters PATERSON Ord Minnett has expanded its corporate finance team with the appointment of Andrew McMillan as a director. 18 Mar 2003
